MARKET

CDXC

CDXC

Chromadex Corp
NASDAQ
5.44
+0.14
+2.64%
Pre Market: 5.55 +0.11 +2.02% 09:05 12/26 EST
OPEN
5.31
PREV CLOSE
5.30
HIGH
5.46
LOW
5.21
VOLUME
168
TURNOVER
0
52 WEEK HIGH
7.97
52 WEEK LOW
1.360
MARKET CAP
415.52M
P/E (TTM)
287.37
1D
5D
1M
3M
1Y
5Y
1D
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
Barchart · 2d ago
Weekly Report: what happened at CDXC last week (1216-1220)?
Weekly Report · 3d ago
Weekly Report: what happened at CDXC last week (1209-1213)?
Weekly Report · 12/16 12:07
Insider Sale: Director at $CDXC (CDXC) Sells 37,161 Shares
Barchart · 12/14 04:20
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable
NASDAQ · 12/09 13:50
Weekly Report: what happened at CDXC last week (1202-1206)?
Weekly Report · 12/09 12:06
Analysts Offer Insights on Healthcare Companies: Chromadex (CDXC) and Sagimet Biosciences, Inc. Class A (SGMT)
TipRanks · 12/08 08:40
Unwarranted negative reaction to ChromaDex 8-K a buying opportunity, says Roth
TipRanks · 12/06 13:49
More
About CDXC
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients, commercialized as Tru Niagen, directly to consumers and distributors. The Ingredients segment develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Ingredients segment provides Niagen in ingredient form to its strategic partners. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Webull offers Chromadex Corp stock information, including NASDAQ: CDXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXC stock methods without spending real money on the virtual paper trading platform.